-
Review
August 19, 2024
- Epidemiology of metabolic dysfunction-associated steatotic liver disease
- Zobair M. Younossi, Markos Kalligeros, Linda Henry
- Clin Mol Hepatol. 2025;31(Suppl):S32-S50.
Articles in E-pub version are posted online ahead of regular printed publication.
- Review
- Tracking the trajectory of kidney dysfunction in cirrhosis: the acute kidney injury – chronic kidney disease spectrum
- Vishnu Girish, Rakhi Maiwall
- Received November 24, 2024 Accepted March 24, 2025
-
DOI: https://doi.org/10.3350/cmh.2024.1060 [Accepted]
-
View: 20 Download: 3
- Editorial
- GULP1, A Multifaceted Diagnostic Biomarker and Potential Therapeutic Target in Hepatocellular Carcinoma: Editorial on “GULP1 as a Novel Diagnostic and Predictive Biomarker in Hepatocellular Carcinoma”
- Yuhao Xie, Lu-Qi Cao, John Wurpel, Zhe-Sheng Chen
- Received March 18, 2025 Accepted March 21, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0315 [Accepted]
-
View: 81 Download: 5
- Besifovir: a viable option for long-term disease control in chronic hepatitis B
- Wai-Kay Seto
- Received March 15, 2025 Accepted March 20, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0305 [Accepted]
-
View: 53 Download: 3
- Refining Portal Hypertension Assessment: The Clinical Significance of Spleen Stiffness Measurement in the Baveno VII Era
- Do Seon Song
- Received March 13, 2025 Accepted March 20, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0296 [Accepted]
-
View: 57 Download: 2
- Letter to the Editor
- Letter “Direct-acting antiviral therapy for patients with HCV-related hepatocellular carcinoma: A nationwide cohort study”
- Qiong Wang, Zhongqing Qian, Xiaodi Yang, Deyan Chen, Xiaojing Wang, Fuliang Chen
- Received March 13, 2025 Accepted March 19, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0291 [Accepted]
-
View: 74 Download: 3
- Correspondence
- Correspondence: Response to the Letter Regarding "GULP1 as a Novel Diagnostic and Predictive Biomarker in Hepatocellular Carcinoma"
- Hyung Seok Kim, Soon Sun Kim, Jae Youn Cheong, Jung Woo Eun
- Received March 12, 2025 Accepted March 15, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0287 [Accepted]
-
View: 193 Download: 16
- Editorial
- Unveiling GULP1 as a Hepatocyte-Specific Role for Recurrence: Editorial on “GULP1 as a Novel Diagnostic and Predictive Biomarker in Hepatocellular Carcinoma”
- Pengde Lu, Ning Wang
- Received March 11, 2025 Accepted March 15, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0282 [Accepted]
-
View: 151 Download: 13
- A non-invasive risk stratification tool for hepatitis B-related liver cirrhosis: the Baveno VI-SSM combined model.
- Ruiling He, Bingtian Dong, Xiaolong Qi
- Received March 11, 2025 Accepted March 15, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0281 [Accepted]
-
View: 168 Download: 12
- Predicting decompensation risk in compensated HBV cirrhosis: Eternal sunshine for a spotless mind?
- Mathias Jachs, Mattias Mandorfer
- Received March 11, 2025 Accepted March 15, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0280 [Accepted]
-
View: 130 Download: 8
- The Evolution of Non-Invasive Strategies in Cirrhosis Management—From Screening to Precision Monitoring：Editorial on ‘FIB-4plus Score: A novel machine learning-based tool for screening high-risk varices in compensated cirrhosis (CHESS2004): An international multicenter study’
- Haiyu Wang, Jinjun Chen
- Received March 9, 2025 Accepted March 15, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0274 [Accepted]
-
View: 144 Download: 4
- Letter to the Editor
- Critical Considerations in Evaluating the Therapeutic Potential of HK-660S for Primary Sclerosing Cholangitis
- He Yizi, He Haifeng, Liang Qi, Xie Yongzhi
- Received March 1, 2025 Accepted March 13, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0239 [Accepted]
-
View: 119 Download: 10
- Original Article
- Impact of components of metabolic syndrome on long-term outcomes of CHB with nucleos(t)ide analogue treatment
- Rui Huang, Dae Won Jun, Hidenori Toyoda, Yao-Chun Hsu, Huy Trinh, Akito Nozaki, Toru Ishikawa, Tsunamasa Watanabe, Haruki Uojima, Daniel Q. Huang, Takashi Honda, Yasuhito Tanaka, Philip Vutien, Sebastián Marciano, Hiroshi Abe, Masaru Enomoto, Masanori Atsukawa, Hirokazu Takahashi, Kunihiko Tsuji, Koichi Takaguchi, Pei-Chien Tsai, Chia-Yen Dai, Jee-Fu Huang, Chung-Feng Huang, Ming-Lun Yeh, Eileen Yoon, Sung Eun Kim, Sang Bong Ahn, Gi-Ae Kim, Jang Han Jung, Soung Won Jeong, Hyunwoo Oh, Cheng-Hao Tseng, Masatoshi Ishigami, Angela Chau, Mayumi Maeda, Satoshi Yasuda, Makoto Chuma, Takanori Ito, Keigo Kawashima, Joanne Kimiko Liu, Adrian Gadano, Ritsuzo Kozuka, Norio Itokawa, Kaori Inoue, Tomonori Senoh, Jie Li, Wan-Long Chuang, Ramsey Cheung, Chao Wu, Ming-Lung Yu, Mindie H. Nguyen
- Received November 27, 2024 Accepted March 14, 2025
-
DOI: https://doi.org/10.3350/cmh.2024.1070 [Accepted]
-
View: 428 Download: 33
- Reply to Correspondence
- SHOULD DIRECT-ACTING ANTIVIRAL BE CONSIDERED FOR ALL PATIENTS WITH HCV-RELATED HEPATOCELLULAR CARCINOMA?
- Yan Ling ONG, Apichat KAEWDECH, Yu Jun WONG
- Received March 5, 2025 Accepted March 10, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0257 [Accepted]
-
View: 166 Download: 8
- Editorial
- Modulation of PRL-1 in Placental MSCs: A Novel Therapeutic Strategy for Hepatic Fibrosis: Editorial on “Modulation of PRL-1 within placental MSCs instigates the transition between EMT and MET subsequent to hepatic fibrosis”
- Lihai Jiang, Wenjie Zheng
- Received March 5, 2025 Accepted March 9, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0264 [Accepted]
-
View: 128 Download: 8
- Regulation of Hepatitis B Virus cccDNA by Metabolic Pathways
- Hyeong-Jin Cho, Sung-Gyoo Park
- Received March 4, 2025 Accepted March 9, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0255 [Accepted]
-
View: 242 Download: 32
- Original Article
- Molecular Classification of Hepatocellular Carcinoma based on Zoned Metabolic Feature and Oncogenic Signaling Pathway
- Tomoko Aoki, Naoshi Nishida, Yutaka Kurebayashi, Kazuko Sakai, Naoto Fujiwara, Masakatsu Tsurusaki, Kohei Hanaoka, Masahiro Morita, Hirokazu Chishina, Masahiro Takita, Satoru Hagiwara, Hiroshi Ida, Kazuomi Ueshima, Yasunori Minami, Atsushi Takebe, Takaaki Murase, Keiko Kamei, Takuya Nakai, Ippei Matsumoto, Kazuto Nishio, Masatoshi Kudo
- Received December 3, 2024 Accepted March 7, 2025
-
DOI: https://doi.org/10.3350/cmh.2024.1088 [Accepted]
-
View: 627 Download: 76
- Letter to the Editor
- Letter “GULP1 as a Novel Diagnostic and Predictive Biomarker in Hepatocellular Carcinoma”
- Juan Yang, Xinyi Li, Sheng Zheng
- Received February 24, 2025 Accepted March 5, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0216 [Accepted]
-
View: 236 Download: 23
- Letter to the Editor on “Current Burden of Steatotic Liver Disease and Fibrosis among Adults in the United States, 2017-2023”
- Sisi Yang, Zhenxuan Ma
- Received February 11, 2025 Accepted March 6, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0153 [Accepted]
-
View: 168 Download: 10
- Correspondence
- Emerging evidence supports direct-acting antiviral therapy for HCC patients beyond the early stage
- Teng-Yu Lee, Pei-Chien Tsai, Shou-Wu Lee, Ming- Lung Yu
- Received February 28, 2025 Accepted March 1, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0235 [Accepted]
-
View: 246 Download: 8
- Reply to Correspondence
- Reply to correspondence on “The Burden of Steatotic Liver Disease before and during the COVID Pandemic”
- Jeayeon Park, Su Jong Yu
- Received February 25, 2025 Accepted February 26, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0226 [Accepted]
-
View: 142 Download: 1
- Research Letter
- Mendelian randomization does not support the effects of G-CSF on decompensated liver disease
- Li Liling, Wang Hui, Wang Hong, Huang Jinchang
- Received February 27, 2025 Accepted March 1, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0172 [Accepted]
-
View: 252 Download: 26
- Review
- Liver Disease Trends in the Asia-Pacific Region for the Next 50 Years
- Shuichiro Shiina, Javkhlan Maikhuu, Qing Deng, Terguunbileg Batsaikhan, Lariza Marie Canseco, Maki Tobari, Hitoshi Maruyama, Hiroaki Nagamatsu, Diana Alcantara-Payawal, Rino Gani, Yi-Hsiang Huang, Tawesak Tanwandee, Giovanni Galati, Yoon Jun Kim
- Received January 15, 2025 Accepted February 26, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0043 [Accepted]
-
View: 320 Download: 22
- Original Article
- CD36 Promotes Iron Accumulation and Dysfunction in CD8+ T Cells via the p38-CEBPB-TfR1 Axis in Early-stage Hepatocellular Carcinoma
- Yifei Qin, Fei Huo, Zhuan Feng, Jialu Hou, Yaxin Ding, Quancheng Wang, Yu Gui, Ziwei Yang, Jiali Yang, Gang Zhou, Ling Li, Jianli Jiang, Lingmin Kong, Shijie Wang, Gang Nan, Dingqiao Xu, Xiaohang Xie, Lijuan Wang, Qian He, Ruibin Yang, Peng Lin, Huijie Bian, Zhi-Nan Chen, Jiao Wu
- Received November 3, 2024 Accepted March 1, 2025
-
DOI: https://doi.org/10.3350/cmh.2024.0948 [Accepted]
-
View: 501 Download: 90
- Erratum
- Erratum to ‘Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: Insights from the IMbrave150 trial’ [Clin Mol Hepatol 2024;30:807-823]
- Sun Young Yim, Sung Hwan Lee, Seung-Woo Baek, Bohwa Sohn, Yun Seong Jeong, Sang-Hee Kang, Kena Park, Hyewon Park, Sunyoung S. Lee, Ahmed O. Kaseb, Young Nyun Park, Sun-Hee Leem, Michael A. Curran, Ji Hoon Kim, Ju-Seog Lee
-
DOI: https://doi.org/10.3350/cmh.2024.0333e [Epub ahead of print]
-
View: 393 Download: 29
- Reply to Correspondence
- Reply to correspondence for “Metabolic dysfunction in patients following DAA-induced viral cure for HCV infection: a non-negligible risk to liver-related health”
- Chen-Hua Liu, Yu-Ping Chang
- Received February 21, 2025 Accepted February 22, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0203 [Accepted]
-
View: 148 Download: 10
- Reply to correspondence on the Editorial “Bridging the Gap: The GOLM1-OPN-ABCG5 Axis in MASH and Gallstone Disease”
- Nahee Hwang, Sungsoon Fang
- Received February 20, 2025 Accepted February 22, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0195 [Accepted]
-
View: 216 Download: 11
- Letter to the Editor
- Re: "Bariatric Surgery Reduces Long-Term Mortality in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease and Cirrhosis"
- Weixiong Zhu, Xuefan Zeng, Zengxi Yang, Yusheng Cheng, Wence Zhou
- Received February 18, 2025 Accepted February 24, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0189 [Accepted]
-
View: 315 Download: 30
- Correspondence
- HCC predictors in routine practice for patients with chronic liver diseases
- Tung-Hung Su, Jia-Horng Kao
- Received February 18, 2025 Accepted February 22, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0187 [Accepted]
-
View: 180 Download: 4
- Correspondence to editorial on “Integrated Molecular Characterization of Sarcomatoid Hepatocellular Carcinoma”
- Rong-Qi Sun, Shao-Lai Zhou
- Received February 17, 2025 Accepted February 22, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0183 [Accepted]
-
View: 205 Download: 8
- Correspondence to Editorial on “Is AMA M2 a Useful Serologic Test for Screening High-Risk Patients for PBC?”
- Haolong Li, Song Liu, Xu Wang, Li Wang, Tengda Xu, Yongzhe Li
- Received February 16, 2025 Accepted February 21, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0181 [Accepted]
-
View: 244 Download: 19
- Reply to “Metabolic dysfunction in patients following DAA-induced viral cure for HCV infection: a nonnegligible risk to liver-related health”
- Tom Ryu, Young Chang, Seung Up Kim, Jae Young Jang
- Received February 15, 2025 Accepted February 21, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0179 [Accepted]
-
View: 163 Download: 7
- Editorial
- Direct-acting antiviral attained sustained virological response improve overall survival in patients with HCV-related hepatocellular carcinoma
- Yan Ling Ong, Apichat Kaewdech, Daniel Q Huang, Yu Jun Wong
- Received February 14, 2025 Accepted February 21, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0174 [Accepted]
-
View: 292 Download: 21
- Letter to the Editor
- Classification of microvascular invasion of hepatocellular carcinoma: different standards, common goals
- Wei Chen, Yihui Rong, Tianshi Ma, Weiwei Shi, Wei Chen, Hang Jiang
- Received February 11, 2025 Accepted February 14, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0167 [Accepted]
-
View: 288 Download: 33
- Letter to the editor on "Bariatric surgery reduces long-term mortality in patients with metabolic dysfunction-associated steatotic liver disease and cirrhosis"
- Wei Wang, Yating Xie, Ailei Xu
- Received February 7, 2025 Accepted February 16, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0140 [Accepted]
-
View: 244 Download: 19
- Correspondence
- Correspondence to “Burden of alcohol use disorder, alcohol-related liver disease, and alcohol-related liver cancer”
- Pojsakorn Danpanichkul, Luis Antonio Diaz, Kanokphong Suparan, Karn Wijarnpreecha, Juan Pablo Arab
- Received February 11, 2025 Accepted February 14, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0166 [Accepted]
-
View: 340 Download: 21
- Response to Editorial on “Exploring Methylation Signatures for High De Novo Recurrence Risk in Hepatocellular Carcinoma”
- Kwang-Woong Lee, Young-Joon Kim
- Received February 11, 2025 Accepted February 14, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0164 [Accepted]
-
View: 234 Download: 13
- Editorial
- Metabolic dysfunction in patients following DAA-induced viral cure for HCV infection: a nonnegligible risk to liver-related health
- Chen-Hua Liu, Yu-Ping Chang
- Received February 9, 2025 Accepted February 14, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0155 [Accepted]
-
View: 211 Download: 23
- Correspondence
- The Burden of Steatotic Liver Disease before and during the COVID Pandemic Correspondence to editorial on “Revealing the importance of a multidisciplinary approach to reducing the global burden of SLD in the COVID-19 pandemic (CMH-2025-0019)”
- Donghee Kim, Pojsakorn Danpanichkul, Karn Wijarnpreecha, George Cholankeril, Rohit Loomba, Aijaz Ahmed
- Received February 9, 2025 Accepted February 14, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0152 [Accepted]
-
View: 226 Download: 6
- Reply to Correspondence
- Decreasing systemic inflammation after TIPS: Still hope for the liver Response to correspondence to an editorial on: TIPS insertion leads to sustained reversal of systemic inflammation in patients with decompensated liver cirrhosis
- Georg SEMMLER, Lorenz BALCAR, Mattias MANDORFER
- Received February 8, 2025 Accepted February 14, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0149 [Accepted]
-
View: 220 Download: 18
- Reply to correspondence on “GOLM1 promotes cholesterol gallstone formation via ABCG5-mediated cholesterol efflux in MASH livers”
- Yoon-su Ha, Won Kim, Seung-Jin Kim
- Received February 4, 2025 Accepted February 12, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0128 [Accepted]
-
View: 422 Download: 19
- Correspondence
- Addressing the Burden of Steatotic Liver Disease: The Role of Transient Elastography: Correspondence to editorial on “Vibration-controlled transient elastography in shaping the epidemiology and management of steatotic liver disease”
- Donghee Kim, Pojsakorn Danpanichkul, Karn Wijarnpreecha, George Cholankeril, Rohit Loomba, Aijaz Ahmed
- Received February 4, 2025 Accepted February 12, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0125 [Accepted]
-
View: 245 Download: 15
- Correspondence to editorial on “Optimal tacrolimus levels for reducing CKD risk and the impact of intrapatient variability on CKD and ESRD development following liver transplantation”
- Soon Kyu Lee, Jong Young Choi
- Received February 3, 2025 Accepted February 12, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0121 [Accepted]
-
View: 202 Download: 16
- GOLM1 and Bile Acid Synthesis: Correspondence to the Editorial “Bridging the Gap: The GOLM1-OPN-ABCG5 Axis in MASH and Gallstone Disease”
- Yi-Tong Li, Wei-Qing Shao, Zhen-Mei Chen, Jing Lin, Jin-Hong Chen
- Received February 3, 2025 Accepted February 12, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0120 [Accepted]
-
View: 271 Download: 19
- Editorial
- Is AMA M2 a Useful Serologic Test for Screening High-Risk Patients for PBC?
- Nae-Yun Heo
- Received February 3, 2025 Accepted February 11, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0117 [Accepted]
-
View: 209 Download: 12
- Can SAFE score be utilized as a universal hepatocellular carcinoma prediction score? Editorial on “High SAFE scores predict hepatocellular carcinoma in viral and non-viral hepatitis and metabolic dysfunction associated steatotic liver disease”
- Michael Kwan-Lung Ko, Loey Lung-Yi Mak
- Received February 3, 2025 Accepted February 7, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0118 [Accepted]
-
View: 230 Download: 15
- Risk stratification for hepatocellular carcinoma in metabolic dysfunction-associated steatotic liver disease
- Ho Soo Chun, Minjong Lee
- Received February 2, 2025 Accepted February 7, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0116 [Accepted]
-
View: 261 Download: 14
- Tetraspan(in)-mediated immune regulation in hepatocellular carcinoma
- Seo Hee Jin, Dong Joo Kim, Jung Weon Lee
- Received January 31, 2025 Accepted February 7, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0109 [Accepted]
-
View: 305 Download: 51
- Screening of patients at high risk of De Novo recurrence in HCC: Editorial on “Exploring Methylation Signatures for High De Novo Recurrence Risk in Hepatocellular carcinoma”
- Ping Huang, Shiqiao Luo, Rui Liao
- Received January 30, 2025 Accepted February 7, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0106 [Accepted]
-
View: 212 Download: 18
- Correspondence
- TIPS insertion and systemic inflammation: Is it ever too late to lower portal pressure?
- Anja Tiede, Benjamin Maasoumy
- Received February 6, 2025 Accepted February 6, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0135 [Accepted]
-
View: 188 Download: 10
- Editorial
- Burden of alcohol use disorder, alcohol-related liver disease, and alcohol-related liver cancer
- Youxin Wang, Noriko Oza, Jazleen Leo, Ashok Choudhury, Daniel Q. Huang
- Received February 5, 2025 Accepted February 6, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0133 [Accepted]
-
View: 465 Download: 41
- TM4SF1 - A new immune target for treatment of hepatocellular carcinoma
- Chen Rui YUAN, Terence Kin Wah LEE
- Received January 29, 2025 Accepted February 6, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0102 [Accepted]
-
View: 275 Download: 24
- Correspondence
- Correspondence to letter to the editor on “Optimal tacrolimus levels for reducing CKD risk and the impact of intrapatient variability on CKD and ESRD development following liver transplantation”
- Soon Kyu Lee, Jong Young Choi
- Received January 28, 2025 Accepted February 6, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0100 [Accepted]
-
View: 206 Download: 12
- Original Article
- Radiogenomics of intrahepatic cholangiocarcinoma predicts immunochemotherapy response and identifies therapeutic target
- Gu-Wei Ji, Zheng-Gang Xu, Shuo-Chen Liu, Shu-Ya Cao, Chen-Yu Jiao, Ming Lu, Biao Zhang, Yue Yang, Qing Xu, Xiao-Feng Wu, Ke Wang, Yong-Xiang Xia, Xiang-Cheng Li, Xue-Hao Wang
- Received October 9, 2024 Accepted February 7, 2025
-
DOI: https://doi.org/10.3350/cmh.2024.0895 [Accepted]
-
View: 5977 Download: 166
- Letter to the Editor
- Letter to the editor on “Bariatric surgery reduces long-term mortality in patients with metabolic dysfunction-associated steatotic liver disease and cirrhosis”
- Chi-Kuei Hsu, Po-Yu Huang, Chih-Cheng Lai
- Received January 19, 2025 Accepted February 4, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0073 [Accepted]
-
View: 260 Download: 15
- Snapshot
- Interventions Targeting the Gut-Liver Axis: A Potential Treatment Strategy for MASLD
- Pingping Jin, Xinyi Lu, Daozhen Chen, Yu Chen
- Received December 2, 2024 Accepted February 4, 2025
-
DOI: https://doi.org/10.3350/cmh.2024.1090 [Accepted]
-
View: 390 Download: 63
- Original Article
- GULP1 as a Novel Diagnostic and Predictive Biomarker in Hepatocellular Carcinoma
- Hyung Seok Kim, Jung Hwan Yoon, Ji Yi Choi, Moon Gyeong Yoon, Geum Ok Baek, Minji Kang, Se Ha Jang, Won Park, Yunjin Go, Jestlin Tianthing Ng, Suk Woo Nam, Jee-Yeong Jeong, Ji Eun Han, Hyo Jung Cho, Su Bin Lim, Soon Sun Kim, Jae Youn Cheong, Jung Woo Eun
- Received November 19, 2024 Accepted February 4, 2025
-
DOI: https://doi.org/10.3350/cmh.2024.1038 [Accepted]
-
View: 1553 Download: 445
- Correspondence
- Correspondence to Editorial on “Targeting TM4SF1 to overcome immunotherapy resistance in hepatocellular carcinoma”
- Weifeng Zeng, Furong Liu, Yachong Liu, Zhanguo Zhang
- Received January 22, 2025 Accepted February 1, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0085 [Accepted]
-
View: 291 Download: 18
- Review
- Deciphering adenosine signaling in hepatocellular carcinoma: pathways, prognostic models, and therapeutic implications
- Huihai Yang, Martina Mang Leng Lei, Longfei Xie, Yinuo Shou, Terence Kin Wah Lee
- Received November 26, 2024 Accepted February 2, 2025
-
DOI: https://doi.org/10.3350/cmh.2024.1068 [Accepted]
-
View: 878 Download: 92
- Original Article
- Direct-acting antiviral therapy for patients with HCV-related hepatocellular carcinoma: A nationwide cohort study
- Shou-Wu Lee, Sheng-Shun Yang, Pei-Chien Tsai, Chung-Feng Huang, Chi-Yi Chen, Chao-Hung Hung, Chien-Hung Chen, Chi-Ming Tai, Pin-Nan Cheng, Hsing-Tao Kuo, Kuo-Chih Tseng, Lein-Ray Mo, Ching-Chu Lo, Yi-Hsiang Huang, Han-Chieh Lin, Pei-Lun Lee, Ming-Jong Bair, Te-Sheng Chang, Chun-Yen Lin, Szu-Jen Wang, Tsai-Yuan Hsieh, Tzeng-Hue Yang, Cheng-Yuan Peng, Chi-Chieh Yang, Lee-Won Chong, Chien-Wei Huang, Chih-Wen Lin, Cheng-Hsin Chu, Ming-Chang Tsai, Jia-Horng Kao, Chun-Jen Liu, Wan-Long Chuang, Teng-Yu Lee, Ming- Lung Yu, on behalf of TACR investigators
- Received November 10, 2024 Accepted January 16, 2025
-
DOI: https://doi.org/10.3350/cmh.2024.1015 [Accepted]
-
View: 959 Download: 74
- FIB-4plus Score: A novel machine learning-based tool for screening high-risk varices in compensated cirrhosis (CHESS2004): An international multicenter study
- Bingtian Dong, Ruiling He, Shenghong Ju, Yuping Chen, Ivica Grgurevic, Jianzhong Ma, Ying Guo, Huizhen Fan, Qiang Yan, Chuan Liu, Huixiong Xu, Anita Madir, Kristian Podrug, Jia Wang, Linxue Qian, Zhengzi Geng, Shanghao Liu, Tao Ren, Guo Zhang, Kun Wang, Meiqin Su, Fei Chen, Sumei Ma, Liting Zhang, Zhaowei Tong, Yonghe Zhou, Xin Li, Fanbin He, Hui Huan, Wenjuan Wang, Yunxiao Liang, Juan Tang, Fang Ai, Tingyu Wang, Liyun Zheng, Zhongwei Zhao, Jiansong Ji, Wei Liu, Jiaojiao Xu, Bo Liu, Xuemei Wang, Yao Zhang, Qiong Yan, Hui Liu, Xiaomei Chen, Shuhua Zhang, Yihua Wang, Yang Liu, Li Yin, Yanni Liu, Yanqing Huang, Li Bian, Ping An, Xin Zhang, Shaoting Zhang, Jinhua Shao, Xiangman Zhang, Wei Rao, Chaoxue Zhang, Christoph Frank Dietrich, Won Kim, Xiaolong Qi
- Received October 10, 2024 Accepted February 3, 2025
-
DOI: https://doi.org/10.3350/cmh.2024.0898 [Accepted]
-
View: 1160 Download: 112
- GDH1-dependent α-ketoglutarate promotes HBV transcription by modulating histone methylations on the cccDNA minichromosome
- Sheng-Tao Cheng, Wei-Xian Chen, Hai-Jun Deng, Xin He, Hui Zhang, Ming Tan, Hai-Bo Yu, Zhen-Zhen Zhang, Ji-Hua Ren, Min-Li Yang, Da-Peng Zhang, Zhi-Hong Li, Juan Chen
- Received August 21, 2024 Accepted January 28, 2025
-
DOI: https://doi.org/10.3350/cmh.2024.0694 [Accepted]
-
View: 793 Download: 157
- Baveno VI-SSM stratifies the risk of portal hypertension-related events in patients with HBV-related cirrhosis
- Haiyu Wang, Weihao Liang, Ling Zhou, Jiankang Song, Biao Wen, Qiaoping Wu, Yuanjian Zhang, Xiaofeng Zhang, Haoran Ke, Yujun Tang, Fuyuan Zhou, Youfu Zhu, Weiqun Wen, Zhihua Liu, Yali Ji, Qintao Lai, Qinjun He, Wenfan Luo, Tingting Qi, Miaoxia Liu, Xiaoqin Lan, Yongpeng Chen, Ranran Xi, Junting Wan, Lin Dai, Yuan Li, Jinjun Chen
- Received July 29, 2024 Accepted January 29, 2025
-
DOI: https://doi.org/10.3350/cmh.2024.0609 [Accepted]
-
View: 560 Download: 67
- Reply to Correspondence
- Reply to correspondence to editorial on “Bariatric Surgery Reduces Long-Term Mortality in Patients with MASLD and Cirrhosis”
- Jing Zeng, Jian-Gao Fan
- Received January 19, 2025 Accepted January 24, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0070 [Accepted]
-
View: 306 Download: 13
- Editorial
- Bridging the Gap: The GOLM1-OPN-ABCG5 Axis in MASH and Gallstone Disease: Editorial on “GOLM1 promotes cholesterol gallstone formation via ABCG5-mediated cholesterol efflux in MASH livers”
- Nahee Hwang, Sungsoon Fang
- Received January 17, 2025 Accepted January 24, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0066 [Accepted]
-
View: 422 Download: 30
- Correspondence
- Correspondence to editorial on “GOLM1 promotes cholesterol gallstone formation via ABCG5-mediated cholesterol efflux in MASH livers”
- Yi-Tong Li, Wei-Qing Shao, Zhen-Mei Chen, Jing Lin, Jin-Hong Chen
- Received January 21, 2025 Accepted January 23, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0079 [Accepted]
-
View: 258 Download: 25
- Editorial
- Intrapatient variability of tacrolimus trough level may be not the cause, but an indirect parameter of comorbidities
- Jongman Kim
- Received January 20, 2025 Accepted January 23, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0076 [Accepted]
-
View: 243 Download: 25
- Genetic Insights into Sarcomatoid Hepatocellular Carcinoma: Critical Role of ARID2 in Pathogenesis and Immune Feature
- Naoshi Nishida
- Received January 19, 2025 Accepted January 23, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0071 [Accepted]
-
View: 257 Download: 17
- Review
- Unveiling the Intratumor Microbiome in Liver Cancer: Current Insights and Prospective Applications
- Xindi Ke, Shangze Jiang, Qiaoxin Wei, Minghao Sun, Hang Sun, Mingchang Pang, Mei Liu, Lejia Sun, Huayu Yang, Yilei Mao
- Received November 19, 2024 Accepted January 20, 2025
-
DOI: https://doi.org/10.3350/cmh.2024.1039 [Accepted]
-
View: 745 Download: 91
- Original Article
- Modulation of PRL-1 within placental MSCs instigates the transition between EMT and MET subsequent to hepatic fibrosis
- Jae Yeon Kim, Hyeri Park, Soo Young Park, Se Ho Kim, Ja Yun Lim, Ki Seog Lee, Si Hyun Bae, Gi Jin Kim
- Received September 12, 2024 Accepted January 20, 2025
-
DOI: https://doi.org/10.3350/cmh.2024.0741 [Accepted]
-
View: 3976 Download: 730
- Letter to the Editor
- What is new in the 2024 Chinese guidelines for fatty liver disease?
- Rui-Xu Yang, Vincent Wai-Sun Wong, Jian-Gao Fan
- Received December 27, 2024 Accepted January 18, 2025
-
DOI: https://doi.org/10.3350/cmh.2024.1165 [Accepted]
-
View: 335 Download: 31
- Original Article
- Switching to Besifovir in Patients with Chronic Hepatitis B Receiving Tenofovir Disoproxil Fumarate: A Randomized Trial
- Hyung Joon Yim, Yeon Seok Seo, Ji Hoon Kim, Won Kim, Young Kul Jung, Jae Young Jang, Sae Hwan Lee, Yun Soo Kim, Chang Wook Kim, Hyoung Su Kim, Jae-Jun Shim, Eun-Young Cho, In Hee Kim, Byung Seok Lee, Jeong-Hoon Lee, Byung Seok Kim, Jeong Won Jang, Hyun Woong Lee, Jung Hyun Kwon, Moon Young Kim, Do Seon Song, Jung Gil Park, Yoon Seok Lee, Eileen L. Yoon, Han Ah Lee, Seong Hee Kang, Jin Mo Yang
- Received September 19, 2024 Accepted January 16, 2025
-
DOI: https://doi.org/10.3350/cmh.2024.0819 [Accepted]
-
View: 1064 Download: 56
- Editorial
- Unraveling the role of GOLM1-OPN-ABCG5 axis in MASH: Editorial on “GOLM1 promotes cholesterol gallstone formation via ABCG5-mediated cholesterol efflux in MASH livers”
- Yoon-su Ha, Won Kim, Seung-Jin Kim
- Received January 10, 2025 Accepted January 13, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0036 [Accepted]
-
View: 584 Download: 29
- Reply to Correspondence
- Reply to correspondence on “Circulating cell-free mitochondrial DNA for diagnosing hepatocellular carcinoma and assessing prognosis”
- Hyuk Soo Eun
- Received January 10, 2025 Accepted January 12, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0035 [Accepted]
-
View: 381 Download: 13
- Editorial
- Targeting TM4SF1 to overcome immunotherapy resistance in hepatocellular carcinoma
- Valerie Chew
- Received January 9, 2025 Accepted January 12, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0031 [Accepted]
-
View: 413 Download: 34
- Revealing the Importance of a Multidisciplinary Approach to Reducing the Global Burden of SLD Through the COVID-19 Pandemic: Editorial on “Current Burden of Steatotic Liver Disease and Fibrosis among Adults in the United States, 2017-2023”
- Jeayeon Park, Su Jong Yu
- Received January 6, 2025 Accepted January 12, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0019 [Accepted]
-
View: 341 Download: 8
- Original Article
- Exploring Methylation Signatures for High De Novo Recurrence Risk in Hepatocellular carcinoma
- Da-Won Kim, Jin Hyun Park, Suk Kyun Hong, Min-Hyeok Jung, Ji-One Pyeon, Jin-Young Lee, Kyung-Suk Suh, Nam-Joon Yi, YoungRok Choi, Kwang-Woong Lee, Young-Joon Kim
- Received October 11, 2024 Accepted January 7, 2025
-
DOI: https://doi.org/10.3350/cmh.2024.0899 [Accepted]
-
View: 375 Download: 40
- Correspondence
- Correspondence to Editorial on “Bariatric Surgery Reduces Long-Term Mortality in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease and Cirrhosis”
- Nicholas A. Rouillard, Linda Henry, Mindie H. Nguyen
- Received January 1, 2025 Accepted January 4, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0001 [Accepted]
-
View: 350 Download: 16
- Letter to the Editor
- Tacrolimus Levels and Variability in CKD and ESRD Risk Post-Liver Transplant
- Rui Shi, Minghua Wang
- Received December 21, 2024 Accepted January 6, 2025
-
DOI: https://doi.org/10.3350/cmh.2024.1159 [Accepted]
-
View: 357 Download: 21
- Original Article
- Adverse impact of metabolic dysfunction on fibrosis regression following direct-acting antiviral therapy: A multicenter study for chronic hepatitis C
- Tom Ryu, Young Chang, Soung Won Jeong, Jeong-Ju Yoo, Sae Hwan Lee, Sang Gyune Kim, Young Seok Kim, Hong Soo Kim, Seung Up Kim, Jae Young Jang
- Received October 12, 2024 Accepted January 5, 2025
-
DOI: https://doi.org/10.3350/cmh.2024.0904 [Accepted]
-
View: 512 Download: 61 Crossref: 1
- Global Epidemiology of Alcohol-Related Liver Disease, Liver Cancer, and Alcohol Use Disorder, 2000–2021
- Pojsakorn Danpanichkul, Luis Antonio Díaz, Kanokphong Suparan, Primrose Tothanarungroj, Supapitch Sirimangklanurak, Thanida Auttapracha, Hanna L. Blaney, Banthoon Sukphutanan, Yanfang Pang, Siwanart Kongarin, Francisco Idalsoaga, Eduardo Fuentes-López, Lorenzo Leggio, Mazen Noureddin, Trenton M. White, Alexandre Louvet, Philippe Mathurin, Rohit Loomba, Patrick S. Kamath, Jürgen Rehm, Jeffrey V. Lazarus, Karn Wijarnpreecha, Juan Pablo Arab
- Received September 26, 2024 Accepted January 3, 2025
-
DOI: https://doi.org/10.3350/cmh.2024.0835 [Accepted]
-
View: 2079 Download: 197 Crossref: 3
- Correspondence
- Correspondence on Editorial regarding “Usefulness of circulating cell-free mitochondrial DNA on hepatocellular carcinoma diagnosis and prognosis assessment”
- Yang Liu, Fan Peng, Siyuan Wang, Jinliang Xing
- Received December 30, 2024 Accepted January 1, 2025
-
DOI: https://doi.org/10.3350/cmh.2024.1185 [Accepted]
-
View: 295 Download: 20
- Editorial
- Treating systemic inflammation by transjugular intrahepatic portosystemic shunt
- Georg Semmler, Lorenz Balcar, Mattias Mandorfer
- Received January 29, 2024 Accepted January 1, 2025
-
DOI: https://doi.org/10.3350/cmh.2024.1180 [Accepted]
-
View: 345 Download: 34
- Correspondence
- Reply to “MAFLD or MASLD: Which Better Represents the Prognosis of the Steatotic Liver Population”
- Seogsong Jeong, Won Kim, Sang Min Park
- Received December 26, 2024 Accepted January 2, 2025
-
DOI: https://doi.org/10.3350/cmh.2024.1175 [Accepted]
-
View: 560 Download: 16
- Reply to “Evolutionary changes in metabolic dysfunction-associated steatotic liver disease and risk of hepatocellular carcinoma”
- Seogsong Jeong, Won Kim, Sang Min Park
- Received December 23, 2024 Accepted January 2, 2025
-
DOI: https://doi.org/10.3350/cmh.2024.1171 [Accepted]
-
View: 544 Download: 14
- Original Article
- High SAFE scores predict hepatocellular carcinoma in viral and non-viral hepatitis and metabolic dysfunction associated steatotic liver disease
- Tung-Hung Su, Sheng-Shun Yang, Mei-Hsuan Lee, Wei-Yu Kao, Shang-Chin Huang, Fen-Fang Chen, Francis SK Poon, Lung-Wen Tsai, Yi-Ting Chen, Che Lin, Weichung Wang, W Ray Kim, Jia-Horng Kao
- Received September 21, 2024 Accepted January 1, 2025
-
DOI: https://doi.org/10.3350/cmh.2024.0822 [Accepted]
-
View: 955 Download: 100
- Male preference for TERT alterations and HBV integration in young-age HBV-related HCC: implications for sex disparity
- Jin Seoub Kim, Hye Seon Kim, Kwon Yong Tak, Ji Won Han, Heechul Nam, Pil Soo Sung, Sung Won Lee, Jung Hyun Kwon, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon, Jeong Won Jang
- Received July 10, 2024 Accepted December 30, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0545 [Accepted]
-
View: 778 Download: 75
- Correspondence
- Age serves as the silent architect of FIB-4's precision in unveiling advanced hepatic fibrosis in MASLD with T2DM
- Ji Won Han, Dae Won Jun
- Received December 22, 2024 Accepted December 26, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.1160 [Accepted]
-
View: 348 Download: 21
- Letter to the Editor
- Current Burden of MASLD, MetALD, and Hepatic Fibrosis among US Adults with Prediabetes and Diabetes, 2017-2023
- Donghee Kim, Rohit Loomba, Aijaz Ahmed
- Received December 20, 2024 Accepted December 29, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.1150 [Accepted]
-
View: 942 Download: 116
- Original Article
- Targeting TM4SF1 promotes tumor senescence enhancing CD8+ T cell cytotoxic function in hepatocellular carcinoma
- Weifeng Zeng, Furong Liu, Yachong Liu, Ze Zhang, Haofan Hu, Shangwu Ning, Hongwei Zhang, Xiaoping Chen, Zhibin Liao, Zhanguo Zhang
- Received October 28, 2024 Accepted December 26, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0934 [Accepted]
-
View: 1284 Download: 213
- Prediction of primary biliary cholangitis among health check-up population with anti-mitochondrial M2 antibody positive
- Haolong Li, Song Liu, Xu Wang, Xinxin Feng, Siyu Wang, Yanli Zhang, Fengchun Zhang, Li Wang, Tengda Xu, Yongzhe Li
- Received June 3, 2024 Accepted December 25, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0416 [Accepted]
-
View: 629 Download: 88 Crossref: 1
- Editorial
- Circulating cell-free mitochondrial DNA for diagnosing hepatocellular carcinoma and assessing prognosis
- Hyuk soo Eun
- Received December 15, 2024 Accepted December 20, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.1133 [Accepted]
-
View: 409 Download: 31
- Vibration-Controlled Transient Elastography in Shaping the Epidemiology and Management of Steatotic Liver Disease
- Xiao-Dong Zhou, Terry Cheuk-Fung Yip, Daniel Q Huang, Mark Dhinesh Muthiah, Mazen Noureddin, Ming-Hua Zheng
- Received December 14, 2024 Accepted December 20, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.1131 [Accepted]
-
View: 886 Download: 38 Crossref: 1
- Letter to the Editor
- MAFLD or MASLD: Which Better Represents the Prognosis of the Steatotic Liver Population
- Ying Wang, Shengfeng Wang, Xiude Fan, Jiajun Zhao, Yongfeng Song
- Received November 8, 2024 Accepted December 24, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.1008 [Accepted]
-
View: 702 Download: 61 Crossref: 1
- Original Article
- Longitudinal profile of plasma pregenomic RNA in patients with chronic hepatitis B infection on long-term nucleoside analogues and its interaction with clinical parameters
- Lung-Yi Mak, Mark Anderson, Michael Stec, Matthew Shing-Hin Chung, Danny Ka-Ho Wong, Rex Wan-Hin Hui, Wai-Kay Seto, Gavin Cloherty, Man-Fung Yuen
- Received August 27, 2024 Accepted December 21, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0724 [Accepted]
-
View: 665 Download: 77
- Correspondence
- Expanding Treatment Eligibility for Chronic Hepatitis B: Balancing Benefits, Limitations, and Healthcare Access
- Yao-Chun Hsu, Chi-Yi Chen, Jaw-Town Lin
- Received December 16, 2024 Accepted December 20, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.1138 [Accepted]
-
View: 336 Download: 13
- Original Article
- MARC1 downregulation reduces hepatocyte lipid content by increasing beta-oxidation
- Ester Ciociola, Tanmoy Dutta, Kavitha Sasidharan, Lohitesh Kovooru, Francesca R. Noto, Grazia Pennisi, Salvatore Petta, Angela Mirarchi, Samantha Maurotti, Bernardette Scopacasa, Luca Tirinato, Patrizio Candeloro, Marcus Henricsson, Daniel Lindén, Oveis Jamialahmadi, Arturo Pujia, Rosellina M. Mancina, Stefano Romeo
- Received August 13, 2024 Accepted December 20, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0642 [Accepted]
-
View: 1460 Download: 267 Crossref: 1
- Editorial
- A leap in the dark: Bariatric surgery for treatment of metabolic dysfunction-associated steatotic liver disease related cirrhosis
- Jing Zeng, Jian-Gao Fan
- Received December 5, 2024 Accepted December 14, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.1099 [Accepted]
-
View: 478 Download: 29
- Letter to the Editor
- Comment on: Evolutionary changes in metabolic dysfunction-associated steatotic liver disease and risk of hepatocellular carcinoma
- Hai Xu, Yong Zhou, Huikun Wu
- Received December 2, 2024 Accepted December 16, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.1087 [Accepted]
-
View: 490 Download: 13
- Global Inequality in the Burden of Hepatitis B From 1990 to 2021: Findings From the Global Burden of Disease Study 2021
- Chunlong Liu, Jiangtao Yu
- Received December 1, 2024 Accepted December 16, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.1085 [Accepted]
-
View: 582 Download: 74
- Original Article
- Plasma lipidomics and fungal peptide-based community analysis identifies distinct signatures of early mortality in acute liver failure
- Neha Sharma, Sushmita Pandey, Gaurav Tripathi, Manisha Yadav, Nupur Sharma, Babu Mathew, Abhishak Gupta, Vasundhra Bindal, Sadam H. Bhat, Yash magar, Rimsha Saif, Sanju Yadav, Amritpal Kaur, Rakhi Maiwall, Shvetank Sharma, Shiv Kumar Sarin, Jaswinder Singh Maras
- Received July 12, 2024 Accepted December 10, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0554 [Accepted]
-
View: 936 Download: 91
- Review Article
- Gut microbiota-mediated gut-liver axis: a breakthrough point for understanding and treating liver cancer
- Chenyang Li, Chujun Cai, Chendong Wang, Xiaoping Chen, Bixiang Zhang, Zhao Huang
- Received September 30, 2024 Accepted December 6, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0857 [Accepted]
-
View: 1188 Download: 156
- Original Article
- Integrated Molecular Characterization of Sarcomatoid Hepatocellular Carcinoma
- Rong-Qi Sun, Yu-Hang Ye, Ye Xu, Bo Wang, Si-Yuan Pan, Ning Li, Long Chen, Jing-Yue Pan, Zhi-Qiang Hu, Jia Fan, Zheng-Jun Zhou, Jian Zhou, Cheng-Li Song, Shao-Lai Zhou
- Received August 21, 2024 Accepted December 6, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0686 [Accepted]
-
View: 1041 Download: 115
- GOLM1 promotes cholesterol gallstone formation via ABCG5-mediated cholesterol efflux in MASH livers
- Yi-Tong Li, Wei-Qing Shao, Zhen-Mei Chen, Xiao-Chen Ma, Chen-He Yi, Bao-Rui Tao, Bo Zhang, Yue Ma, Guo Zhang, Rui Zhang, Yan Geng, Jing Lin, Jin-Hong Chen
- Received August 12, 2024 Accepted December 5, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0657 [Accepted]
-
View: 1192 Download: 193 Crossref: 1
- Editorial
- Reconsidering Treatment Indications for Chronic Hepatitis B: Insights from the TORCH-B Roll-Over Study
- Chih-Wen Wang, Ming-Lung Yu
- Received November 28, 2024 Accepted November 30, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.1078 [Accepted]
-
View: 450 Download: 15
- Letter to the Editor
- Treatment response to nucleos(t)ide analogs in chronic hepatitis B with mildly elevated alanine aminotransferase
- Jian Wang, Fei Cao, Chuanwu Zhu, Chao Wu, Rui Huang
- Received October 29, 2024 Accepted November 29, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0960 [Accepted]
-
View: 404 Download: 17
- Original Article
- Cost-effectiveness and return on investment of hepatitis C virus elimination in China: A modelling study
- Meiyu Wu, Jing Ma, Xuehong Wang, Sini Li, Chongqing Tan, Ouyang Xie, Andong Li, Aaron G Lim, Xiaomin Wan
- Received August 13, 2024 Accepted December 2, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0664 [Accepted]
-
View: 886 Download: 122
- Correspondence
- HCV Self-Testing: Bridging Screening Gaps and Ensuring Cost-Effectiveness for Both High-Risk and Universal Populations
- Gyeongseon Shin, Beom Kyung Kim, SeungJin Bae, Hankil Lee, Sang Hoon Ahn
- Received November 23, 2024 Accepted November 26, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.1057 [Accepted]
-
View: 404 Download: 22
- Original Article
- Current Burden of Steatotic Liver Disease and Fibrosis among Adults in the United States, 2017-2023
- Donghee Kim, Pojsakorn Danpanichkul, Karn Wijarnpreecha, George Cholankeril, Rohit Loomba, Aijaz Ahmed
- Received November 3, 2024 Accepted November 26, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0987 [Accepted]
-
View: 2023 Download: 361 Crossref: 5
- Editorial
- Universal self-testing as a cost-effective weapon to eliminate hepatitis C virus in the Republic of Korea
- Eun Sun Jang
- Received November 5, 2024 Accepted November 7, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0992 [Accepted]
-
View: 418 Download: 9
- Correspondence
- Correspondence to editorials on “Safety and efficacy of HK-660S in patients with primary sclerosing cholangitis: A randomized double-blind phase 2a trial”
- Woo Hyun Paik, Do Hyun Park
- Received November 4, 2024 Accepted November 7, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0989 [Accepted]
-
View: 392 Download: 25
- Review
- Stem cell exosomes: new hope and future potential for relieving liver fibrosis
- Lihua Li, Yongjie Liu, Kunpeng Wang, Jinggang Mo, Zhiyong Weng, Hao Jiang, Chong Jin
- Received September 29, 2024 Accepted November 5, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0854 [Accepted]
-
View: 1782 Download: 261
- Editorial
- Stabilizing Hepatic Fatty Acid Oxidation: USP29 Secures Acyl-CoA Synthesis through ACSL5
- Myeung Gi Choi, Na Young Lee, Ja Hyun Koo
- Received October 31, 2024 Accepted November 1, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0971 [Accepted]
-
View: 594 Download: 51
- A novel clinical trial for primary sclerosing cholangitis from Asia: all regional endeavors should improve global management of PSC
- Atsumasa Komori
- Received October 25, 2024 Accepted November 1, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0945 [Accepted]
-
View: 437 Download: 27
- Correspondence
- Correspondence on Letter Regarding “Contemporary Awareness of Viral Hepatitis between 2012 and 2022 among Korean Adults”
- Chang Hun Lee, In Hee Kim, Sook-Hyang Jeong
- Received October 25, 2024 Accepted November 1, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0944 [Accepted]
-
View: 474 Download: 9
- Editorial
- Challenges and Innovations in PSC Clinical Trials: Evaluating HK-660S and the Path Forward
- Nilanga Nishad
- Received October 24, 2024 Accepted October 31, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0942 [Accepted]
-
View: 380 Download: 23
- Momentum Towards Simplifying and Expanding Treatment for Chronic Hepatitis B: The Body of Evidence Continues to Grow
- Robert J. Wong
- Received October 22, 2024 Accepted October 28, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0929 [Accepted]
-
View: 358 Download: 15
- Letter to the Editor
- Prevalence of steatotic liver disease and associated fibrosis in the general population: an epidemiological survey
- Lin Guan, Xinhe Zhang, Shanghao Liu, Xiaolong Qi, Yiling Li
- Received October 17, 2024 Accepted October 28, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0921 [Accepted]
-
View: 623 Download: 59
- Snapshot
- MODULATION OF LYMPHATIC VESSELS IN MANAGEMENT OF LIVER DISEASE AND COMPLICATIONS
- Aarti Sharma, Pinky Juneja, Shiv K Sarin, Savneet Kaur
- Received September 12, 2024 Accepted October 16, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0793 [Accepted]
-
View: 494 Download: 43
- Correspondence
- Reply to: “From invasive to intuitive: the emerging role of non-invasive models in hepatic decompensation”
- Chuan Liu, Ling Yang, Hong You, Gao-Jun Teng, Xiaolong Qi
- Received August 27, 2024 Accepted August 29, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0723 [Accepted]
-
View: 658 Download: 30
- Editorial
- From Invasive to Intuitive: The Emerging Role of Non-Invasive Models in Hepatic Decompensation
- Akhil Deshmukh, Rakhi Maiwall
- Received August 13, 2024 Accepted August 13, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0661 [Accepted]
-
View: 1500 Download: 18
